Lv2
140 积分 2023-11-07 加入
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
2天前
已完结
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
2天前
已完结
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study
2天前
已完结
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
2天前
已完结
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study
2天前
已完结
53750 Improvements in Patient-Reported Symptoms and Signs of Moderate-to-Severe Psoriasis With JNJ-77242113: Results of the FRONTIER 1 Study
8天前
已关闭
A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose
8天前
已完结
Unlocking biological barriers: nonclinical safety considerations for RNA-based complex biologics
11天前
已完结
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trial
1个月前
已完结
Surface area of the hand and digits
1个月前
已完结
皖公网安备34019202002308